SOURCE: SuperSonic Imagine

SuperSonic Imagine

April 01, 2015 12:15 ET

SuperSonic Imagine Appoints Tom Egelund as President and Chief Executive Officer

AIX-EN-PROVENCE, FRANCE--(Marketwired - Apr 1, 2015) - SuperSonic Imagine (EURONEXT PARIS: SSI) (Euronext: SSI, FR0010526814), a company specializing in ultrasound medical imaging, today confirmed the appointment of Tom Egelund as President and Chief Executive Officer. This marks the end of the six-month transition period that was announced upon Mr. Egelund's arrival at SuperSonic Imagine as Chief Operating Officer on September 1st, 2014.

As previously communicated, Tom Egelund succeeds Jacques Souquet as President and CEO on April 1st 2015. Jacques Souquet, who founded the Company, will now transition to the post of Chief Innovation Officer and will remain a member of the Executive Committee where he will continue to be fully engaged with Supersonic Imagine, concentrating on the company's innovation strategy with a particular focus on novel ultrasound product concepts and their clinical application.

"It is a pleasure to welcome Tom to the post of Chief Executive Officer. SuperSonic Imagine is transitioning to a new phase of growth with an emphasis on facilitating commercial traction in key international markets. Tom's expertise in managing fast growing companies at this stage of development will be extremely helpful to the team. On behalf of the Supervisory Board, I also wish to extend sincere appreciation to Jacques Souquet for the remarkable research, development and commercial achievements that he has accomplished at SuperSonic Imagine since inception. We are delighted that Jacques will continue to lead SuperSonic Imagine's innovation strategies. His unique expertise will be invaluable for developing our product portfolio for tomorrow," commented Hans Barella, Chairman of the Supervisory Board.

Tom Egelund has a strong track record of successfully driving growth and earnings. Before joining SuperSonic Imagine, he spent 10 years as Executive Vice President of Océ, a publicly listed company developing, manufacturing and selling printing and copying hardware and related software products, which became part of the Canon Group in 2011. In this role, he led organic growth programs as well as acquisitions and post-merger integrations. He was actively involved in all industry processes, from technology development to commercialization. A doctor by training, he has held senior executive positions in large international companies such as Philips Medical Systems where he managed the Danish Division of Philips Health Care (previously Philips Medical Systems) and was responsible for Latin America and EMEA regions with 4,500 employees and a turnover of EUR 2 billion. Mr. Egelund graduated in medicine from Aarhus University (Denmark) where he also studied marketing.

"I'm extremely excited to have Tom assume the role of Chief Executive Officer. This is an important milestone for the Company as we actively expand commercial operations and his appointment will enable me to focus purely on creating promising opportunities through new technology breakthroughs in non-invasive ultrasound imaging to better address a wide range of health concerns such as cancer and vascular disease," commented Jacques Souquet.

About SuperSonic Imagine

Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer® is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™ Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer® in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.

For more information about SuperSonic Imagine, please go to www.supersonicimagine.com

Contact Information